Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/30/23 → 1/30/26 |
Funding
- Parexel (Prot. R5459-RT-1944 // Prot. R5459-RT-1944)
- Regeneron Pharmaceuticals, Inc. (Prot. R5459-RT-1944 // Prot. R5459-RT-1944)
Prot. R5459-RT-1944: A Dose Escalation and Proof-Of-Concept Study of REGN5459 or REGN5458 (BCMA × CD3 Bispecific Antibodies) for Desensitization of Chronic Kidney Disease Patients in Need of Kidney Transplantation Who Are Highly Sensitized to Human Leukoc
- Friedewald, John J (PD/PI)
Project: Research project